4.2 Article

Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia Beyond Ibrutinib

Journal

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
Volume 35, Issue 4, Pages 761-773

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.hoc.2021.03.006

Keywords

BTK inhibitors; Toxicity; Side effects; Next-generation BTK inhibitors; CLL; Efficacy; Resistance

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available